On the other hand, p-tau species could potentially be used to diagnose both ALS and AD, thus calling into question the recently proposed inclusion of blood p-tau 181 and p-tau 217 as accurate screening tests for AD pathology. The gene discussed is MAPT; the disease is Alzheimer disease.